News | January 05, 2023
Biocytogen and Hansoh Pharma announce an antibody license agreement
Biocytogen will provide a license to Hansoh Pharma for their selected fully human antibody molecules
Biocytogen will provide a license to Hansoh Pharma for their selected fully human antibody molecules
Passengers arriving from 6 high-risk countries are now mandatorily required to upload their negative RT-PCR test
The company is one of the most profitable companies manufacturing speciality chemicals in India
Tafasitamab is conditionally approved by both the U.S. Food and Drug Administration and European Medicines Agency
Yonghe as the CDMO partner will provide production process development and cGMP manufacturing services for Ablaze
Centre and states need to work in tandem and in a collaborative spirit as was done during the previous surges for COVID-19 prevention and management
First PARP inhibitor and new hormonal agent combination approved for these patients in Europe
Her previous role at Novartis, where she was general manager, data & digital, in global drug development, also included accountability for driving the DCT strategy, programs and platforms
LG Chem will receive totaling up to $95.5 million for the China rights
GlobalData predicts the average prices of dual chamber pacemakers in both India and China are expected to reduce at an average CAGR of -3.42% from 2022 to 2025.
Subscribe To Our Newsletter & Stay Updated
